Table 1.
Clinical, surgical and pathologic characteristics for patients with endometrioid and serous endometrial carcinomas staged with bilateral sentinel lymph node mapping from 2005–2018 (N=1,044)
| Endometrioid (n=959) n (%) |
Serous (n=85) n (%) |
|
|---|---|---|
| Median age, years (range) | 60 (24–92) | 68 (49–89) |
| Median BMI, kg/m2 (range) | 30 (15–70) | 30 (18–54) |
| One or both ovaries retained | 33 (3) | 0 |
| Median lymph nodes removed (range) | 3 (2–16) | 3 (2–11) |
| FIGO grade | ||
| 1 | 713 (74) | NA |
| 2 | 178 (19) | |
| 3 | 68 (7) | |
| Myoinvasion | ||
| None | 530 (55) | 41 (48) |
| Inner half (<50%) | 309 (32) | 23 (27) |
| Outer half (≥50%) | 120 (13) | 21 (25) |
| FIGO Stage | ||
| IA | 805 (84) | 50 (59) |
| IB | 82 (9) | 10 (12) |
| II | 19 (2) | 6 (7) |
| IIIA | 10 (1) | 2 (2) |
| IIIC | 40 (4) | 11 (13) |
| IVB | 3 (<1) | 6 (7) |
BMI, body mass index; SLN, sentinel lymph node; FIGO, International Federation of Gynecology and Obstetrics